lobbying_activities: 3090865

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts. Sortable columns (indexed): client_name, issue_code, filing_year, filing_uuid. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	is_no_activity	is_termination	received_date
3090865	9ef089e9-06c1-4cb5-9b55-f8005c3e972c	Q4	BLUEBIRD STRATEGIES	401105447	BOEHRINGER INGELHEIM USA CORPORATION	2023	fourth_quarter	MMM	H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics.	HOUSE OF REPRESENTATIVES,SENATE	0	0	2024-01-05T17:47:23-05:00